As global markets experience mixed performances and economic indicators remain closely watched, the Hong Kong market has shown resilience, particularly with the Hang Seng Index gaining 2.14% recently. In this climate, identifying strong small-cap stocks can be crucial for investors seeking growth opportunities amidst broader market fluctuations. A good stock in today's environment often demonstrates robust fundamentals, strategic positioning within its industry, and potential for sustainable growth despite economic uncertainties.

Top 10 Undiscovered Gems With Strong Fundamentals In Hong Kong

Name Debt To Equity Revenue Growth Earnings Growth Health Rating S.A.S. Dragon Holdings 60.96% 4.62% 10.02% ★★★★★★ Lion Rock Group 16.91% 14.33% 10.15% ★★★★★★ Changjiu Holdings NA 11.84% 2.46% ★★★★★★ Sundart Holdings 0.92% -2.32% -3.94% ★★★★★★ Tianyun International Holdings 10.09% -5.59% -9.92% ★★★★★★ Xin Point Holdings 1.77% 10.88% 22.83% ★★★★★☆ Chongqing Machinery & Electric 28.07% 8.82% 11.12% ★★★★★☆ HBM Holdings 52.89% 66.59% 31.70% ★★★★★☆ Time Interconnect Technology 212.50% 27.21% 15.01% ★★★★☆☆ Billion Industrial Holdings 3.63% 18.00% -11.38% ★★★★☆☆

Click here to see the full list of 174 stocks from our SEHK Undiscovered Gems With Strong Fundamentals screener.

We're going to check out a few of the best picks from our screener tool.

IVD Medical Holding

Simply Wall St Value Rating: ★★★★★☆

Overview: IVD Medical Holding Limited, an investment holding company with a market cap of HK$2.13 billion, distributes in vitro diagnostic (IVD) products in Mainland China and internationally.

Operations: IVD Medical Holding generates revenue primarily through its distribution business (CN¥2.86 billion), after-sales services (CN¥196.47 million), and self-branded products business (CN¥9.05 million).

IVD Medical Holding, a small cap in Hong Kong, reported half-year sales of CNY 1.35 billion and net income of CNY 125.29 million for June 2024, up from CNY 103.01 million last year. Earnings per share rose to CNY 0.0927 from CNY 0.0762 previously. Over the past five years, its debt-to-equity ratio increased from 5.4% to 23.3%. Despite dilution in the past year, earnings grew by 12.3%, showing robust performance against industry trends (-11%).

Click here and access our complete health analysis report to understand the dynamics of IVD Medical Holding. Examine IVD Medical Holding's past performance report to understand how it has performed in the past.SEHK:1931 Earnings and Revenue Growth as at Sep 2024

Dah Sing Banking Group

Simply Wall St Value Rating: ★★★★★☆

Overview: Dah Sing Banking Group Limited, an investment holding company with a market cap of HK$9.69 billion, provides banking, financial, and other related services in Hong Kong, Macau, and the People’s Republic of China.

Story Continues

Operations: The company's revenue streams include Personal Banking (HK$2.68 billion), Corporate Banking (HK$853.60 million), Treasury and Global Markets (HK$1.34 billion), and Mainland China and Macau Banking (HK$176.27 million).

Dah Sing Banking Group, with total assets of HK$262.4B and equity of HK$33.6B, has seen earnings grow 32.3% over the past year, outpacing the Banks industry average of 3.2%. The bank's net income for the first half of 2024 was HK$1.40B compared to HK$1.11B a year ago, reflecting strong performance despite insufficient allowance for bad loans at 43%. Trading at nearly 47% below its estimated fair value, it offers potential upside for investors seeking undervalued opportunities in Hong Kong's financial sector.

Click to explore a detailed breakdown of our findings in Dah Sing Banking Group's health report. Assess Dah Sing Banking Group's past performance with our detailed historical performance reports.SEHK:2356 Earnings and Revenue Growth as at Sep 2024

Dah Sing Financial Holdings

Simply Wall St Value Rating: ★★★★★☆

Overview: Dah Sing Financial Holdings Limited is an investment holding company offering banking, insurance, financial, and related services across Hong Kong, Macau, and the People’s Republic of China with a market cap of HK$7.57 billion.

Operations: Dah Sing Financial Holdings generates revenue primarily from Personal Banking (HK$2.68 billion), Treasury and Global Markets (HK$1.34 billion), and Corporate Banking (HK$853.60 million). The Insurance Business contributes HK$246.25 million, while Mainland China and Macau Banking add HK$176.27 million to the total revenue stream.

Dah Sing Financial Holdings, with total assets of HK$272.4B and equity of HK$42.4B, reported net income for the first half of 2024 at HK$1.11B, up from HK$921.86M a year ago. Total deposits stand at HK$214.2B against loans of HK$141.9B, showing solid financial health with low-risk funding sources comprising 93% liabilities and an appropriate bad loan allowance at 43%. The company announced an interim dividend of HKD 0.92 per share for June 2024.

Delve into the full analysis health report here for a deeper understanding of Dah Sing Financial Holdings. Learn about Dah Sing Financial Holdings' historical performance.SEHK:440 Earnings and Revenue Growth as at Sep 2024

Taking Advantage

Click through to start exploring the rest of the 171 SEHK Undiscovered Gems With Strong Fundamentals now. Are these companies part of your investment strategy? Use Simply Wall St to consolidate your holdings into a portfolio and gain insights with our comprehensive analysis tools. Maximize your investment potential with Simply Wall St, the comprehensive app that offers global market insights for free.

Ready To Venture Into Other Investment Styles?

Explore high-performing small cap companies that haven't yet garnered significant analyst attention. Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management. Find companies with promising cash flow potential yet trading below their fair value.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Companies discussed in this article include SEHK:1931 SEHK:2356 and SEHK:440.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email [email protected]

View Comments